Integra LifeSciences Holdings Corp

Insider trading at Integra LifeSciences shows modest CFO sales amid mixed signals; learn how this impacts short‑term volatility and long‑term growth prospects.

Insightful look at Singh Harvinder’s insider trades at Integra LifeSciences—strategic buying at vesting, selling at $9.55‑$9.61, and the implications for investors.

Insider trades at Integra LifeSciences reveal routine liquidity moves amid strong RSU grants, while the firm’s neuro‑stimulation pipeline and outpatient device focus promise future growth.